Quanterix (QTRX) Cash & Equivalents Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | -52.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.71% |
| Dec 31, 2025 | -47.38% |
| Sep 30, 2025 | 30.54% |
| Jun 30, 2025 | 182.75% |
| Mar 31, 2025 | 68.96% |
| Dec 31, 2024 | -67.49% |
| Sep 30, 2024 | -85.42% |
| Jun 30, 2024 | -85.74% |
| Mar 31, 2024 | -86.25% |
| Dec 31, 2023 | -48.51% |
| Sep 30, 2023 | -41.45% |
| Jun 30, 2023 | -8.86% |
| Mar 31, 2023 | -12.07% |
| Dec 31, 2022 | -14.56% |
| Sep 30, 2022 | -16.31% |
| Jun 30, 2022 | -16.07% |
| Mar 31, 2022 | -15.39% |
| Dec 31, 2021 | 118.34% |
| Sep 30, 2021 | 137.20% |
| Jun 30, 2021 | 385.08% |
| Mar 31, 2021 | 359.40% |
| Dec 31, 2020 | 66.35% |
| Sep 30, 2020 | 52.80% |
| Jun 30, 2020 | 23.30% |
| Mar 31, 2020 | 183.64% |
| Dec 31, 2019 | 145.68% |
| Sep 30, 2019 | 120.38% |
| Jun 30, 2019 | 19.10% |
| Mar 31, 2019 | -47.92% |
| Dec 31, 2018 | -44.24% |
| Mar 31, 2018 | 165.57% |
| Dec 31, 2017 | 168.55% |